+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Gliadel"

From
US Glioma - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

US Glioma - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • April 2023
  • 200 Pages
  • United States
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Gliadel is a brand of chemotherapy drug used to treat brain cancer. It is a wafer that is implanted directly into the brain tumor during surgery. The wafer contains a chemotherapy drug called carmustine, which is slowly released over time. The drug is designed to kill cancer cells and reduce the size of the tumor. Gliadel is used in combination with other treatments, such as radiation therapy and surgery, to improve the chances of survival. Gliadel is a part of the larger brain cancer drug market, which includes a variety of treatments, such as chemotherapy, radiation therapy, and immunotherapy. The market is highly competitive, with many companies offering different treatments. Some of the major players in the market include Bristol-Myers Squibb, Merck, Pfizer, Novartis, and Roche. Show Less Read more